The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial

• Published in: BMC nephrology Vol. 20; no. 1; p. 179
• Main Authors: Raimann, Jochen G, Abbas, Samer R, Liu, Li, Larive, Brett, Beck, Gerald, Kotanko, Peter, Levin, Nathan W, Handelman, Garry
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 17.05.2019; BioMed Central; BMC
• Subjects: Acids; Anemia; Ascorbic acid; Clinical trials; Complications and side effects; Frequent hemodialysis network (FHN); Hemodialysis; Hemoglobin; High-performance liquid chromatography; Homeostasis; Iron; Kinases; Left ventricular mass; Metabolism; More frequent hemodialysis; Mortality; Nephrology; Parathyroid hormone; Patient outcomes; Physical health component score; Proteins; Regression analysis; Risk factors; Systematic review; Vitamin C; Vitamin C deficiency; Vitamin deficiency; Vitamins; United States; Frequent hemodialysis network (FHN); Hemodialysis; More frequent hemodialysis; Vitamin C; Clinical trials; Left ventricular mass; Physical health component score
• ISSN: 1471-2369; 1471-2369
• DOI: 10.1186/s12882-019-1311-4

Reports on vitamin C in HD patients have shown effects of vitamin C deficiency in association with scurvy symptoms. Dialyzability of water soluble vitamins is high, and substantial losses in those who are dialyzed more frequently were hypothesized. The randomized FHN Daily Trial compared the effects of in-center HD six versus three times per week. We studied baseline correlations between vitamin C and potentially associated parameters, and the effect of more frequent HD on circulating vitamin C concentrations. We studied vitamin C levels at baseline and months, 3, 5 and 11. Patients enrolled between 2007 and 2009 into the randomized FHN Daily trial in the East Coast consortium were approached for participation. Predialysis plasma samples were processed with metaphosphoric acid and frozen at - 70 °C for measurement with HPLC. Regression models between baseline log-transformed vitamin C and hemoglobin, CRP, eKt/V, ePCR and PTH, and a linear mixed-effects model to estimate the effect size of more frequent HD on plasma vitamin C, were constructed. We studied 44 subjects enrolled in the FHN Daily trial (50 ± 12 years, 36% female, 29% Hispanics and 64% blacks, 60% anuric). Vitamin C correlated significantly with predialysis hemoglobin (r = 0.3; P = 0.03) and PTH (r = - 0.3, P = 0.04), respectively. Vitamin C did not significantly differ at baseline (6×/week, 25.8 ± 25.9 versus 3×/week, 32.6 ± 39.4 μmol/L) and no significant treatment effect on plasma vitamin C concentrations was found [- 26.2 (95%CI -57.5 to 5.1) μmol/L at Month 4 and - 2.5 (95%CI -15.6 to 10.6) μmol/L at Month 12. Based on data from this large randomized-controlled trial no significant effect of the intervention on circulating plasma vitamin C concentrations was found, allaying the concerns that more frequent HD would affect the concentrations of water-soluble vitamins and adversely affect patient's well-being. Correlations between vitamin C and hemoglobin and PTH support the importance of vitamin C for normal bone and mineral metabolism, and anemia management.